Renal Anemia Treatment in the Us- How Payer Policies and Physician Preferences Drive Prescribing and How will the Emerging Oral HIF-PH Inhibitors Influence Payers and Physicians?

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1009
https://www.valueinhealthjournal.com/article/S1098-3015(16)32375-0/fulltext
Title : Renal Anemia Treatment in the Us- How Payer Policies and Physician Preferences Drive Prescribing and How will the Emerging Oral HIF-PH Inhibitors Influence Payers and Physicians?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32375-0&doi=10.1016/j.jval.2016.09.1009
First page : A520
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 947
Categories :
Tags :
Regions :
ViH Article Tags :